Improved malar projection with transconjunctival hydroxyapatite granules

Current facial augmentation techniques often rely on alloplastic materials to enhance malar projection. While these implants provide structural support, they may carry risks such as migration or extrusion. Prior research has shown that porous hydroxyapatite granules can integrate with surrounding tissues, offering a potential alternative. However, the long-term stability and patient satisfaction of such materials remain uncertain. No prior work had resolved whether transconjunctival placement of hydroxyapatite granules could achieve lasting malar projection. That uncertainty drove this investigation into the cosmetic and reconstructive use of hydroxyapatite granules. This gap motivated the development of a minimally invasive technique to address malar hypoplasia. The study aimed to determine if this approach could offer both measurable and sustained improvements in facial contour.

This study aimed to evaluate the effectiveness of transconjunctival hydroxyapatite granule placement in enhancing malar projection. The specific problem addressed was the lack of long-term data on this technique’s ability to maintain augmentation. Researchers sought to assess patient satisfaction and the durability of malar enhancement. The motivation stemmed from the need for safer, less invasive alternatives to traditional implants. By measuring changes in malar projection pre- and post-surgery, the study aimed to quantify the procedure’s impact. The goal was to determine if this method could provide stable results over time. Researchers also aimed to evaluate the safety profile of the technique. The study focused on both cosmetic and reconstructive applications of the procedure.

The study involved eight patients who underwent transconjunctival placement of hydroxyapatite granules. Malar projection was measured using lateral facial views at three time points: preoperative, postoperative, and one-year follow-up. Measurements were calculated as the right-angle distance from the malar prominence to the nasale-subnasale line. A transconjunctival incision allowed access to subperiosteal malar pockets for granule placement. No additional fixation methods were used to secure the granules. Patient satisfaction was assessed using a subjective rating scale. Statistical analysis compared pre- and postoperative measurements to determine significance. The study design focused on both quantitative and qualitative outcomes.

Postoperative malar projection showed a significant increase compared to preoperative measurements. The improvement was maintained at the one-year follow-up, indicating stability. Six out of eight patients reported being very satisfied with the results. Two patients were satisfied but not highly so. No major complications were reported during the follow-up period. The transconjunctival approach allowed for precise placement of granules without visible scarring. The granules remained in place without migration or extrusion. These findings suggest that hydroxyapatite granules can provide lasting facial augmentation.

The authors propose that transconjunctival hydroxyapatite granule placement is a viable option for malar augmentation. The results suggest that this technique can achieve measurable and sustained improvements in malar projection. Patient satisfaction was high, with six of eight patients reporting very high satisfaction. The absence of major complications supports the safety of the procedure. The maintenance of projection over one year indicates the durability of the granules. The transconjunctival approach allows for minimal scarring and precise placement. The findings suggest that this method could be used for both cosmetic and reconstructive purposes. The study supports the use of hydroxyapatite granules as an alternative to traditional implants.